FIELD: medicine; phthisiology. SUBSTANCE: process of ethiopathogenetic therapy involved dimephosphone. EFFECT: more effective treatment of pulmonary tuberculosis characterized by predominatingly exudative inflammation. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT ENHANCING EFFECTIVENESS OF TREATMENT OF PATIENTS WITH TUBERCULOSIS | 1996 |
|
RU2136276C1 |
METHOD FOR TREATING ACUTE MILIARY PULMONARY TUBERCULOSIS | 1999 |
|
RU2188034C2 |
METHOD FOR TREATING TUBERCULOSIS | 2003 |
|
RU2235537C1 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS AT PREDOMINANTLY PRODUCTIVE TYPE OF TISSUE REACTION | 2000 |
|
RU2204409C2 |
COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
METHOD FOR TREATING THE CASES OF EXPERIMENTAL TUBERCULOSIS | 2000 |
|
RU2165761C1 |
METHOD OF TREATMENT OF EXPERIMENTAL TUBERCULOSIS | 2001 |
|
RU2207127C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
Authors
Dates
1994-03-15—Published
1990-11-27—Filed